---
title: "\"Performance\" Lao Heng He Brewing's annual loss narrowed to 514 million RMB"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/281035771.md"
description: "Lao Heng He Brewing announced its annual results for 2025, with revenue recorded at RMB 272 million, a year-on-year decrease of 1.2%. The loss narrowed from RMB 517 million in the previous year to RMB 514 million, with a loss per share of 89 cents. No final dividend will be distributed"
datetime: "2026-03-30T14:01:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281035771.md)
  - [en](https://longbridge.com/en/news/281035771.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281035771.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281035771.md) | [English](https://longbridge.com/en/news/281035771.md)


# "Performance" Lao Heng He Brewing's annual loss narrowed to 514 million RMB

Lao Heng He Brewing (02226.HK) announced its 2025 annual performance, with revenue recorded at RMB 272 million, a year-on-year decrease of 1.2%. The loss narrowed from RMB 517 million in the previous year to RMB 514 million, with a loss per share of 89 cents. No final dividend will be distributed

### 相關股票

- [HONWORLD GP (02226.HK)](https://longbridge.com/zh-HK/quote/02226.HK.md)

## 相關資訊與研究

- [A C-Suite executive at Pop Mart's biggest Chinese competitor explains what goes into making a hit toy like Labubu](https://longbridge.com/zh-HK/news/281606541.md)
- [Laopu Gold Co. Ltd. Class H (6181) Receives a Buy from CGS International](https://longbridge.com/zh-HK/news/281138022.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [China Youran Dairy Further Delays Circular on Share Subscription and Whitewash Waiver](https://longbridge.com/zh-HK/news/281536370.md)
- [Tesla Robotaxis Will Be Covering 70% of US Population in 2 Weeks](https://longbridge.com/zh-HK/news/281483553.md)